Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05027633
Title Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

paranasal sinus cancer

Therapies

Cisplatin + Docetaxel + Pembrolizumab

Carboplatin + Docetaxel + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.